| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |